v3.26.1
Condensed Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Collaboration revenue $ 6,560
Operating expenses    
Research and development 95,726 70,886
General and administrative 19,378 13,503
Total operating expenses 115,104 84,389
Loss from operations (108,544) (84,389)
Interest income and other income, net 10,005 12,211
Net loss (98,539) (72,178)
Unrealized (losses) gains on marketable securities (2,761) 773
Comprehensive loss $ (101,300) $ (71,405)
Net loss per common share, basic $ (1.11) $ (0.82)
Weighted-average common shares outstanding, basic 88,699,754 88,356,335
Net loss per common share, diluted $ (1.11) $ (0.82)
Weighted-average common shares outstanding, diluted 88,699,754 88,356,335